'Milestone' reached as world edges closer to vaccine

90% effective

Adam Saville
clock • 1 min read

The RNA vaccine uses an experimental approach that involves injecting part of the virus’ genetic code

The first effective coronavirus vaccine has been developed by American pharmaceutical giant Pfizer and German technology company BioNTech, it is being widely reported in the media. The revolutionary new RNA vaccine technology, which has been tested on 43,500 people in six countries and has no safety concerns so far, is more than 90% effective, trails have shown. Of the dozen or so vaccines in the final phase 3 stage testing, this is the first to show results and the developers plan to apply for emergency approval to use the vaccine by the end of the month. Two doses, three weeks ap...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

Private healthcare invoices slow in 2025: Healthcode
PMI

Private healthcare invoices slow in 2025: Healthcode

1.6% slowdown in Q3 2025

Cameron Roberts
clock 28 October 2025 • 1 min read
NHS patients receive 6.15m private appointments and tests
PMI

NHS patients receive 6.15m private appointments and tests

"We’re not prepared to continue 2-tier healthcare"

Jaskeet Briah
clock 27 October 2025 • 3 min read
National Friendly launches healthcare product
PMI

National Friendly launches healthcare product

No medical questions or underwriting

Jaskeet Briah
clock 14 October 2025 • 2 min read